Pursuant to Regulation 30 and 47 of the SEBI LODR Regulation, we hereby submit the copies of the extract of audited financials results of the Company for the 4th Quarter and year ended ....
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudeep Pharma Ltd has filed a disclosure under SEBI LODR Regulations 30 and 47 regarding the publication of its Q4 and full-year FY2026 financial results. The company submitted its audited standalone and consolidated financial results to the stock exchanges on 21st May 2026. Extracts of these results were published in Business Standard (English) and Vadodara Samachar (regional language) newspapers on 22nd May 2026. The full results are also available on the company's website at sudeeppharma.com. This is a routine regulatory compliance filing for listed companies.
This is a standard disclosure filing confirming that quarterly and annual financial results have been made public as required by SEBI regulations. The actual financial performance numbers and their implications for shareholders would be contained in the underlying financial results, not in this publication notice.